Pages that link to "Q48334770"
Jump to navigation
Jump to search
The following pages link to Detection of Lewy bodies in Trisomy 21 (Down's syndrome). (Q48334770):
Displaying 15 items.
- α-Synuclein modifies huntingtin aggregation in living cells (Q24298430) (← links)
- Down's syndrome and Parkinson's disease (Q33715018) (← links)
- Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy (Q34062509) (← links)
- Dementia with Lewy bodies in Down's syndrome (Q34208554) (← links)
- α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila (Q35163459) (← links)
- Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes (Q35754459) (← links)
- Lewy-body formation is an aggresome-related process: a hypothesis (Q35840040) (← links)
- Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline (Q35840610) (← links)
- Examining the mechanisms that link β-amyloid and α-synuclein pathologies (Q38006559) (← links)
- Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration (Q48550467) (← links)
- beta-Amyloid (A beta) deposition in the medial temporal lobe of patients with dementia with Lewy bodies (Q48705293) (← links)
- Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway (Q48728006) (← links)
- Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies (Q49135439) (← links)
- α-Synuclein Oligomers Induce a Unique Toxic Tau Strain. (Q52686361) (← links)
- Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome. (Q55023507) (← links)